European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 137, Issue 1 , Pages 21-26, March 2008

Pregnancy outcome in obese and morbidly obese gestational diabetic women

  • Yariv Yogev

      Affiliations

    • Corresponding Author InformationCorresponding author at: Department of Obstetrics and Gynecology, St. Luke's-Roosevelt Hospital Center, 1000 Tenth Avenue, Suite 11A, New York, NY 10019, USA. Tel.: +1 212 523 5750; fax: +1 212 523 8066.
  • ,
  • Oded Langer

Department of Obstetrics and Gynecology, St. Luke's-Roosevelt Hospital Center, University Hospital of Columbia University, New York, NY, USA

Received 7 November 2006; received in revised form 27 January 2007; accepted 14 March 2007. published online 10 May 2007.

Abstract 

Objective

We sought to determine whether pregnancy outcome differs between obese and morbidly obese GDM patients and to assess pregnancy outcome in association with mode of treatment and level of glycemic control.

Methods

A cohort study of 4830 patients with gestational diabetes (GDM), treated in the same center using the same diabetic protocol, was performed. Obesity was defined as prepregnancy BMI >30 and <35kg/m2; morbid obesity was defined as prepregnancy BMI ≥35kg/m2. Well-controlled GDM was defined as mean blood glucose <105mg/dl. Pregnancy outcome measures included the rates of large for gestational age (LGA) and macrosomic babies, metabolic complications, the need for NICU admission and/or respiratory support, rate of shoulder dystocia, and the rate of cesarean section.

Results

Among the GDM patients, the rates of obesity and morbid obesity were 15.7% (760 out of 4830, BMI: 32.4±1.6kg/m2) and 11.6% (559 out of 4830, BMI: 42.6±2.2kg/m2), respectively. No differences were found with regard to maternal age, ethnicity, gestational age at delivery or oral glucose tolerance test (OGTT) results. Moreover, similar rates of cesarean section, fetal macrosomia, shoulder dystocia, composite outcome, and metabolic complications were noted. Insulin treatment was initiated for 62% of the obese and 73% of the morbidly obese GDM patients (P<0.002). Similar rates of obese and morbidly obese patients achieved desired levels of glycemic control (63% versus 61%, respectively). In both obese and morbidly obese patients who achieved a desired level of glycemic control (<105mg/dl), no difference was found in pregnancy outcome except that both neonatal metabolic complications and composite outcomes were more prevalent in diet-treated subjects in comparison to insulin-treated GDM patients.

Conclusion

In obese women with GDM, pregnancy outcome is compromised regardless of the level of obesity or treatment modality.

Keywords: Obesity, Morbid obesity, Gestational diabetes, Pregnancy

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0301-2115(07)00187-X

doi:10.1016/j.ejogrb.2007.03.022

European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 137, Issue 1 , Pages 21-26, March 2008